Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat

Davidson, E. P., Holmes, A., Coppey, L. J., & Yorek, M. A.

European journal of pharmacology 765 (2015): 258-267.

We have previously demonstrated that treating diabetic rats with enalapril, an angiotensin converting enzyme (ACE) inhibitor, α-lipoic acid, an antioxidant, or menhaden oil, a natural source of omega-3 fatty acids can partially improve diabetic peripheral neuropathy. In this study we sought to determine the efficacy of combining these three treatments on vascular and neural complications in a high fat fed low dose streptozotocin treated rat, a model of type 2 diabetes. Rats were fed a high fat diet for 8 weeks followed by a 30 mg/kg dose of streptozotocin. Eight weeks after the onset of hyperglycemia diabetic rats were treated with a combination of enalapril, α-lipoic acid and menhaden oil. Diabetic rats not receiving treatment were continued on the high fat diet. Glucose clearance was impaired in diabetic rats and significantly improved with treatment. Diabetes caused steatosis, elevated serum lipid levels, slowing of motor and sensory nerve conduction, thermal hypoalgesia, reduction in intraepidermal nerve fiber profiles, decrease in cornea sub-basal nerve fiber length and corneal sensitivity and impairment in vascular relaxation to acetylcholine and calcitonin gene-related peptide in epineurial arterioles of the sciatic nerve. Treating diabetic rats with the combination of enalapril, α-lipoic acid and menhaden oil reversed all these deficits to near control levels except for motor nerve conduction velocity which was also significantly improved compared to diabetic rats but remained significantly decreased compared to control rats. These studies suggest that a combination therapeutic approach may be most effective for treating vascular and neural complications of type 2 diabetes.

Effect-of-combination-therapy-consisting-of-enalapril-lipoic-acid-and-menhaden-oil-on-diabetic-neuropathy-in-a-high-fat-low-dose-streptozotocin-treated-rat

Products Used in this Publication

Catalog NumberCASProduct NamePrice
75847-73-375847-73-3EnalaprilInquiry

Related Products

Catalog NumberCASProduct NamePrice
B0084-07790981938-43-4Zofenopril calciumInquiry
76095-16-476095-16-4Enalapril MaleateInquiry
84680-54-684680-54-6Enalaprilat DihydrateInquiry
B0084-340551167305-00-2OmapatrilatInquiry
1356922-29-61356922-29-6Enalaprilat D5 Sodium SaltInquiry